Abstract
Purpose
The optimal treatment for pediatric Graves’ disease (GD) is controversial. Antithyroid drugs are often used initially, but they are associated with a high failure rate. Therefore alternative therapies have become important. In the present study, we analyze our institution’s experience regarding the safety and efficacy of thyroid surgery among pediatric patients with GD.
Methods
This is a retrospective chart review of 27 pediatric patients (age ≤ 18 years) with GD who underwent thyroid surgery between 1991 and 2009 at a single academic Institution. We recorded preoperative, intraoperative, and short-term postoperative data.
Results
All 27 patients were initially treated with thionamides. The high rate of hyperthyroidism relapse after discontinuation of medical treatment, age < 5 years, adverse reaction to medical therapy, severe ophthalmopathy, and patient preference justified the final decision to proceed with surgery as definitive therapy. All patients underwent total thyroidectomy. We had no mortality; surgical complications were rare: 4 (14.8 %) cases of transient hypocalcemia, 1 (3.7 %) of permanent hypocalcemia, 3 (11.1 %) of transient RLN neuropraxia, and 2 (7 %) of keloid scar. No bleeding, permanent RLN palsy or relapse hyperthyroidism were reported.
Conclusions
Surgical therapy for pediatric GD performed by experienced thyroid surgeons is a safe, definitive and cost-effective treatment.
Similar content being viewed by others
Abbreviations
- ATD:
-
Antithyroid drug therapy
- BMI:
-
Body mass index
- GD:
-
Graves’ disease
- RAI:
-
Radioactive iodine ablation
- RLN:
-
Recurrent laryngeal nerve
- TPOAb:
-
Thyroid peroxidase autoantibodies
- TRAb:
-
Thyroid-stimulating hormone receptor antibodies
- TT:
-
Total thyroidectomy
References
Glaser NS, Styne DM (2008) Organization of pediatric endocrinologists of northern California collaborative Graves’ disease study group: predicting the likelihood of remission in children with Graves’ disease: a prospective, multicenter study. Pediatrics 121(3):e481–e488
Shulman DI, Muhar I, Jorgensen EV, Diamond FB, Bercu BB, Root AW (1997) Autoimmune hyperthyroidism in prepubertal children and adolescents: comparison of clinical and biochemical features at diagnosis and responses to medical therapy. Thyroid 7(5):755–760
Kaguelidou F, Alberti C, Castanet M, Guitteny MA, Czernichow P, Léger J (2008) French Childhood Graves’ Disease Study Group: predictors of autoimmune hyperthyroidism relapse in children after discontinuation of antithyroid drug treatment. J Clin Endocrinol Metab 93(10):3817–3826
Lazar L, Kalter-Leibovici O, Pertzelan A, Weintrob N, Josefsberg Z, Phillip M (2000) Thyrotoxicosis in prepubertal children compared with pubertal and postpubertal patients. J Clin Endocrinol Metab 85(10):3678–3682
Read CH Jr, Tansey MJ, Menda Y (2004) A 36-year retrospective analysis of the efficacy and safety of radioactive iodine in treating young Graves’ patients. J Clin Endocrinol Metab 89(9):4229–4233
Safa AM, Schumacher OP, Rodriguez-Antunez A (1975) Long-term follow-up results in children and adolescents treated with radioactive iodine (131I) for hyperthyroidism. N Engl J Med 292(4):167–171
Hayek A, Chapman EM, Crawford JD (1970) Long-term results of treatment of thyrotoxicosis in children and adolescents with radioactive iodine. N Engl J Med 283(18):949–953
Crile G Jr, Schumacher OP (1965) Radioactive iodine treatment of Graves’ disease: results in 32 children under 16 years of age. Am J Dis Child 110(5):501–504
Freitas JE, Swanson DP, Gross MD, Sisson JC (1979) Iodine-131: optimal therapy for hyperthyroidism in children and adolescents? J Nucl Med 20(8):847–850
Starr P, Jaffe HL, Oettinger L Jr (1969) Later results of 131-I treatment of hyperthyroidism in 73 children and adolescents: 1967 follow-up. J Nucl Med 10(9):586–590
Lee JA, Grumbach MM, Clark OH (2007) The optimal treatment for pediatric Graves’ disease is surgery. J Clin Endocrinol Metab 92(3):801–803
Peters H, Fischer C, Bogner U, Reiners C, Schleusener H (1997) Treatment of Graves’ hyperthyroidism with radioiodine: results of a prospective randomized study. Thyroid 7(2):247–251
Peters H, Fischer C, Bogner U, Reiners C, Schleusener H (1996) Reduction in thyroid volume after radioiodine therapy of Graves’ hyperthyroidism: results of a prospective, randomized, multicenter study. Eur J Clin Invest 26(1):59–63
Tallstedt L, Lundell G (1997) Radioiodine treatment, ablation, and ophthalmopathy: a balanced perspective. Thyroid 7(2):241–245
Bartalena L, Marcocci C, Bogazzi F, Manetti L, Tanda ML, Dell’Unto E, Bruno-Bossio G, Nardi M, Bartolomei MP, Lepri A, Rossi G, Martino E, Pinchera A (1998) Relation between therapy for hyperthyroidism and the course of Graves’ ophthalmopathy. N Engl J Med 338(2):73–78
Krassas GE (2003) Ophthalmic complications in juvenile Graves’ disease—clinic and therapeutic approaches. Pediatr Endocrinol Rev 1(Suppl 2):223–229 (discussion 229)
Lavard L, Ranløv I, Perrild H, Andersen O, Jacobsen BB (1994) Incidence of juvenile thyrotoxicosis in Denmark, 1982–1988: a nationwide study. Eur J Endocrinol 130(6):565–568
Rivkees SA, Mattison DR (2009) Propylthiouracil (PTU) hepatoxicity in children and recommendations for discontinuation of use. Int J Pediatr Endocrinol 2009:132041
Miccoli P, Vitti P, Rago T, Iacconi P, Bartalena L, Bogazzi F, Fiore E, Valeriano R, Chiovato L, Rocchi R, Pinchera A (1996) Surgical treatment of Graves’ disease: subtotal or total thyroidectomy? Surgery 120(6):1020–1024
Palit TK, Miller CC 3rd, Miltenburg DM (2000) The efficacy of thyroidectomy for Graves’ disease: a meta-analysis. J Surg Res 90(2):161–165
Lal G, Ituarte P, Kebebew E, Siperstein A, Duh QY, Clark OH (2005) Should total thyroidectomy become the preferred procedure for surgical management of Graves’ disease? Thyroid 15(6):569–574
Sosa JA, Bowman HM, Tielsch JM, Powe NR, Gordon TA, Udelsman R (1998) The importance of surgeon experience for clinical and economic outcomes from thyroidectomy. Ann Surg 228(3):320–330
Erbil Y, Ozluk Y, Giriş M, Salmaslioglu A, Issever H, Barbaros U, Kapran Y, Ozarmağan S, Tezelman S (2007) Effect of Lugol solution on thyroid gland blood flow and microvessel density in the patients with Graves’ disease. J Clin Endocrinol Metab 92(6):2182–2189
Grodski S, Stalberg P, Robinson BG, Delbridge LW (2007) Surgery versus radioiodine therapy as definitive management for Graves’ disease: the role of patient preference. Thyroid 17(2):157–160
Boostrom S, Richards ML (2007) Total thyroidectomy is the preferred treatment for patients with Graves’ disease and a thyroid nodule. Otolaryngol Head Neck Surg 136(2):278–281
Schüssler-Fiorenza CM, Bruns CM, Chen H (2006) The surgical management of Graves’ disease. J Surg Res 133(2):207–214
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Peroni, E., Angiolini, M.R., Vigone, M.C. et al. Surgical management of pediatric Graves’ disease: an effective definitive treatment. Pediatr Surg Int 28, 609–614 (2012). https://doi.org/10.1007/s00383-012-3095-5
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00383-012-3095-5